StockData
PTCHFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as PRTCY

PureTech Health plc

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$1.48+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

PureTech Health plc revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018% of revenueYoY
Parent Company and Other$4.66M$4.32M$2.31M$13.60M$6.51M$2.05M$137.00K$29.00K100.0%+8.0%
Wholly-Owned Programs$0$513.00K$270.00K–––––0.0%-100.0%
Controlled Founded Entities$0$0$750.00K–––––0.0%–
Controlled Founded Entities–$0$750.00K$1.50M$1.50M$2.76M$1.66M$18.50M––
Wholly-Owned Programs–$513.00K$270.00K$521.00K$9.38M–––––
Non-controlled founded entities–––$81.00K$115.00K$93.00K$0$20.00K––
Internal–––$2.83M$9.38M$6.86M$8.01M$2.20M––
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018YoY
Controlled Founded Entities-$821.00K-$845.00K-$483.00K–––––-2.8%
Parent Company and Other-$30.41M-$70.03M-$45.71M-$81.42M-$85.76M–––-56.6%
Wholly-Owned Programs-$67.30M-$65.22M-$100.00M–––––+3.2%
Controlled Founded Entities–-$845.00K-$483.00K$30.00K$216.00K––––
Wholly-Owned Programs–-$65.22M-$100.00M-$116.42M-$64.74M––––

By product or service

By region

From the segment and revenue-disaggregation notes of PureTech Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.